UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Nature (London), ISSN 0028-0836, 02/2017, Volume 542, Issue 7642, pp. 456 - 460
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Exobiology | Temperature | Planets | Water - analysis | Water - chemistry | Stars, Celestial | Extraterrestrial Environment - chemistry | Terrestrial planets | Discovery and exploration | Extrasolar planets | Earth | Space telescopes | Solar system | Stars & galaxies | Light | Index Medicus | Physics - Earth and Planetary Astrophysics | Earth and Planetary Astrophysics | Sciences of the Universe | Astrophysics
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 389, Issue 10080, pp. 1699 - 1709
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Severity of Illness Index | Interleukin-23 Subunit p19 - antagonists & inhibitors | Double-Blind Method | Drug Administration Schedule | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Gastrointestinal Agents - administration & dosage | Antibodies, Monoclonal - therapeutic use | Male | Treatment Outcome | Remission Induction | Dose-Response Relationship, Drug | Young Adult | Antibodies, Monoclonal - administration & dosage | Crohn Disease - drug therapy | Adolescent | Gastrointestinal Agents - therapeutic use | Adult | Female | Aged | Gastrointestinal Agents - adverse effects | Clinical trials | Monoclonal antibodies | Medicine, Experimental | Medical research | Interleukins | Intravenous administration | Pathogenesis | Mucosa | Interleukin | Interleukin 23 | Antagonists | Evidence-based medicine | Intravenous therapy | Randomization | Endoscopes | Motivation | Gastroenterology | Remission | Tumor necrosis factor-TNF | Colon | Safety | Active control | Chronic illnesses | Psoriasis | Cytokines | Ileitis | Nausea | Inflammation | Crohn's disease | Disease control | Patients | Ileum | Crohns disease | Inflammatory bowel disease | Interactive systems | Tumor necrosis factor | Ulcers | TNF inhibitors | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2012, Volume 380, Issue 9857, pp. 1909 - 1915
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Biological and medical sciences | General aspects | Medical sciences | Other diseases. Semiology | Steroids - administration & dosage | Acute Disease | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Antibodies, Monoclonal - therapeutic use | Male | Cyclosporine - therapeutic use | Infliximab | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Treatment Failure | Adult | Female | Colitis, Ulcerative - drug therapy | Infusions, Intravenous | Drug Resistance | Complications and side effects | Dosage and administration | Cyclosporine | Research | Drug therapy | Ulcerative colitis | Inflammatory bowel disease | Substance abuse treatment | Heart attacks | Human immunodeficiency virus--HIV | Pharmaceutical industry | Drug resistance | Drug dosages | Steroids | Surgery | Infections | Viral infections | Index Medicus | Abridged Index Medicus | Drugs | International organizations | Side effects | Mortality | Clinical trials | corticoids | Organic chemistry | Chemical Sciences
Journal Article
Nature genetics, ISSN 1061-4036, 2008, Volume 40, Issue 8, pp. 955 - 962
Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Fundamental and applied biological sciences. Psychology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Biological and medical sciences | Genetics of eukaryotes. Biological and molecular evolution | Medical sciences | Other diseases. Semiology | Crohn Disease - genetics | Genetic Predisposition to Disease | Genome, Human | Quantitative Trait Loci | Humans | Physiological aspects | Crohn's disease | Genetic aspects | Research | Genetic susceptibility | Risk factors | Inflammatory bowel disease | Studies | Medical research | Genetics | Genomics | Crohns disease | Index Medicus
Journal Article
Gut, ISSN 0017-5749, 02/2013, Volume 62, Issue 2, pp. 201 - 208
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Pharmacology. Drug treatments | Bones, joints and connective tissue. Antiinflammatory agents | Biological and medical sciences | Medical sciences | Immunomodulators | Other diseases. Semiology | Severity of Illness Index | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Certolizumab Pegol | Follow-Up Studies | Humans | Immunoglobulin Fab Fragments - adverse effects | Endoscopy, Gastrointestinal | Polyethylene Glycols - adverse effects | Male | Treatment Outcome | Immunoglobulin Fab Fragments - therapeutic use | Polyethylene Glycols - therapeutic use | Remission Induction | Intestinal Mucosa - drug effects | Young Adult | Crohn Disease - drug therapy | Injections, Subcutaneous | Crohn Disease - diagnosis | Adult | Female | Intestinal Mucosa - pathology | Physiological aspects | Care and treatment | Crohn's disease | Research | Patient outcomes | Intestinal mucosa | Bowel disease | Ulcers | Gangrene | Tumor necrosis factor-TNF | Family medical history | Endoscopy | Crohns disease | Index Medicus | Abridged Index Medicus | Certolizumab pegol | anti-TNF agent | endoscopic response | Inflammatory Bowel Disease | 1506 | mucosal healing
Journal Article
Alimentary pharmacology & therapeutics, ISSN 0269-2813, 01/2016, Volume 43, Issue 2, pp. 252 - 261
Gastroenterology & Hepatology | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Inflammatory Bowel Diseases - drug therapy | Urologic Neoplasms - epidemiology | Prospective Studies | Humans | Middle Aged | Risk Factors | Urologic Neoplasms - etiology | Proportional Hazards Models | Male | Incidence | Young Adult | Adult | Female | Cohort Studies | Inflammatory bowel diseases | Kidneys | Health risks | Bladder | Urinary tract | Risk analysis | Patients | Risk factors | Inflammatory bowel disease | Intestine | Health risk assessment | Urogenital system | Cancer | Index Medicus | Life Sciences | Microbiology and Parasitology | Molecular biology | Biochemistry, Molecular Biology | Bacteriology
Journal Article
The American journal of gastroenterology, ISSN 0002-9270, 12/2008, Volume 103, Issue 12, pp. 3106 - 3114
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Pharmacology. Drug treatments | Bones, joints and connective tissue. Antiinflammatory agents | Biological and medical sciences | Medical sciences | Other diseases. Semiology | Single-Blind Method | Colitis, Ulcerative - complications | Humans | Middle Aged | Proctitis - drug therapy | Proctocolitis - drug therapy | Administration, Rectal | Male | Treatment Outcome | Young Adult | Proctitis - etiology | Enema - methods | Adolescent | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Aged, 80 and over | Proctocolitis - etiology | Adult | Female | Aged | Colitis, Ulcerative - drug therapy | Dosage Forms | Mesalamine - administration & dosage | Mesalamine | Antifungal agents | Ulcerative colitis | Index Medicus
Journal Article